e-Procurement – e-Notification

Management data

Awarding authority

Sciensano 

File reference number

Sciensano-000-ONCNGS (1)-F02 

Title

Pre–commercial procurement to buy R&D services for the development of a solution for analysis in liquid biopsies of solid tumours based on NGS technology 

Description

The mutational profiling of tumours requires complex, invasive and expensive procedures but is rapidly becoming essential for an efficient and adequate provision of care for cancer patients, especially when the disease has already advanced to metastatic conditions, in which the identification of tumour biomarkers is relevant to identify the best targeted therapy. However, access to tumour tissue remains a limiting factor for the assessment of biomarkers, and mounting evidence suggests that may even be inadequate to capture the clonal heterogeneity that often drives resistance. The assessment of circulating biomarkers is rapidly gaining ground as a non-invasive alternative that offers the additional possibility of serially monitoring disease evolution and the potential to obtain a more comprehensive picture of the tumour genetic heterogeneity. However, the current development trajectory for large cfDNA tests is heavily reliant on costly, high throughput centralized sequencing and appears ill-suited for European common practice. The oncNGS PCP aims at developing an integrated solution for predictive, prognostic and diagnostic analysis in liquid biopsies of solid tumours (including appropriate haematological indications) based on NGS technology. This PCP tackles the common global unmet need in oncology to profile multiple tumours at the molecular level in the broadest possible way, promoting an economically sustainable and de-centralised model that allows a secure and transparent access to sensitive data. All partners in this consortium do agree that they face a common challenge in providing ‘the best NGS tests, for all solid and lymphoid tumours, forever’. They agree that a commonly identified procurement meets a need that is shared by all procurers in the Buyers Group of the project that forms the object of the here proposed PCP procurement ‘oncNGS’. More information regarding the goal of the oncNGS PCP and the PCP Challenge can be found in Annex 2 – Challenge Brief, as well as the technical and functional specifications.  

Contract type

Services 

Procedure type

Open procedure 

Tenders submission deadline

07/02/2022 

TED publication number

2022/S 011-024896 

TED publication link

http://ted.europa.eu/udl?uri=TED:NOTICE:024896-2022:TEXT:FR:HTML 

BDA/ Free Market publication number

2022-501029 

 

 

Invitation to submit

Notices

Reference Number	Title	LG	Type	Purpose	Dispatch date	Link to TED
Sciensano-000-ONCNGS (1)-F03_0	Pre–commercial procurement to buy R&D services for the development of a solution for analysis in liquid biopsies of solid tumours based on NGS technology	[en, fr, nl]	F3	STOP	20/06/2022	http://ted...
Sciensano-000-ONCNGS (1)-F01_0	Pre–commercial procurement to buy R&D services for the development of a solution for analysis in liquid biopsies of solid tumours based on NGS technology	[en, fr, nl]	F1	PIN	15/04/2021	http://ted...
Sciensano-000-ONCNGS (1)-F02_1 (E)	Pre–commercial procurement to buy R&D services for the development of a solution for analysis in liquid biopsies of solid tumours based on NGS technology	[en, fr, nl]	F14	EDA	12/01/2022	http://ted...
Sciensano-000-ONCNGS (1)-F02_0	Pre–commercial procurement to buy R&D services for the development of a solution for analysis in liquid biopsies of solid tumours based on NGS technology	[en, fr, nl]	F2	CN	02/12/2021	http://ted...
Sciensano-000-ONCNGS (1)-F02_1	Pre–commercial procurement to buy R&D services for the development of a solution for analysis in liquid biopsies of solid tumours based on NGS technology	[en, fr, nl]	F2	CN	12/01/2022	http://ted...

Procurement documents